Back
Innoviva 10K Form
Buy
66
INVA
Innoviva
Last Price:
$18.60
Seasonality Move:
4.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INVA News And Ratings
See the #1 stock for the next 7 days that we like better than INVA
INVA Financial Statistics
Sales & Book Value
| Annual Sales: | $358.7M |
|---|---|
| Cash Flow: | $48.6M |
| Price / Cash Flow: | 6.86 |
| Annual Sales: | $10.31 |
| Price / Book: | 1.8 |
Profitability
| EPS (TTM): | -1.01000 |
|---|---|
| Net Income (TTM): | $-59.7M |
| Gross Margin: | $322.1M |
| Return on Equity: | -8.85% |
| Return on Assets: | -4.76% |
Innoviva Earnings Forecast
Key Innoviva Financial Ratios
-
The Gross Profit Margin over the past 25 years for INVA is 89.80%.
-
The Selling, General & Administrative Expenses for INVA have been equal to 32.25% of Gross Profit Margin.
-
The Research & Development expenses have been 3.81% of Revenue.
-
The Interest Expense is 94.94% of Operating Income.
-
The Net Earning history of INVA is 6.52% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 16 years.
Innoviva Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | INVA |
| CUSIP: | 45781M |
| Website: | inva.com |
Debt
| Debt-to-Equity Ratio: | 0.69 |
|---|---|
| Current Ratio: | 2.48 |
| Quick Ratio: | 2.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 51.56 |
|---|---|
| Forward P/E Ratio: | 6.93 |